CapForce IBD Breakout Opp... (BOUT)
: BOUT
· 실시간 가격 · USD
45.26
+0.26 (0.57%)
종가 기준: Aug 17, 2026, 11:50 AM
CapForce IBD Breakout Opportunities ETF (BOUT) ETF Price, Holdings & Analysis
| 매수호가 | n/a |
| 시가총액 | n/a |
| 운용자산 | 16.18M |
| 순자산가치 | 44.79 |
| 베타 | 1.14 |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | n/a |
| 발행 주식수 | n/a |
| 설정일 | Sep 12, 2018 |
| 매도호가 | n/a |
| 거래량 | n/a |
| 평균 거래량 (20일) | n/a |
| 시가 | n/a |
| 전일 종가 | n/a |
| 당일 변동폭 | n/a - n/a |
| 52주 변동폭 | n/a - n/a |
| 편입 종목 | n/a |
| 총보수 | 0.80% |
BOUT 정보
The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.
주요 섹터
| 섹터 | 비중 % |
|---|---|
| Financial Services | 38.61% |
| Healthcare | 38.48% |
| Consumer Cyclical | 10.83% |
| Industrials | 7.81% |
| Energy | 2.07% |
상위 10종목 자산의 61.05%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Enliven Therapeutics... | ELVN | 7.26% |
| Bicara Therapeutics ... | BCAX | 7.04% |
| U.S. Bancorp | USB | 6.92% |
| Travere Therapeutics... | TVTX | 6.84% |
| Waste Management Inc | WM | 6.66% |
| Interface Inc | TILE | 6.26% |
| Ubs Group Ag Registe... | UBSG.SW | 6.13% |
| The Goldman Sachs Gr... | GS | 4.71% |
| Bank Of America Corp | BAC | 4.63% |
| Pnc Financial Servic... | PNC | 4.60% |
배당 배당수익률 0.28%
| 배당락일 | 금액 | 지급일 |
|---|---|---|
| Dec 31, 2025 | $0.1250 | n/a |
| Dec 31, 2024 | $0.2280 | n/a |
| Jul 31, 2024 | $0.0060 | n/a |
| Dec 28, 2023 | $0.4370 | n/a |
| Dec 29, 2022 | $0.3980 | n/a |